⌘K
Loading ticker…
Eli Lilly & Co. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Eli Lilly & Co. (LLY) has a 3-month relative strength percentile of 84 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 62. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.3%, relative volume 2.35×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 84, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
LLY is in a stage 2 uptrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 17.1% / 23.8%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
LLY is held by 19 ETFs as of Mar 2026. Top owner: VTI at 1.25% weight, $24.8B notional. Top 3 carry $52.7B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 1.25% | $24.8B |
| VOOVanguard S&P 500 ETF | 1.30% | $18.5B |
| IVViShares Core S&P 500 ETF | 1.30% | $9.4B |
| SPYState Street SPDR S&P 500 ETF | 1.30% | $8.5B |
| VUGVanguard Growth ETF | 2.60% | $8.3B |
| XLVState Street Health Care Select Sector SPDR ETF | 13.74% | $5.3B |
| IWFiShares Russell 1000 Growth ETF | 2.66% | $3.0B |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 1.30% | $1.5B |
| IVWiShares S&P 500 Growth ETF | 2.51% | $1.5B |
| SPYGState Street SPDR Portfolio S&P 500 Growth ETF | 2.51% | $1.0B |
Showing 10 of 19 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LLY Jan avg: 1.60% median: 0.78% win: 50% σ: 7.71% n: 4 2022-04-12 → 2026-05-29 | LLY Feb avg: 5.53% median: 7.47% win: 75% σ: 12.03% n: 4 2022-04-12 → 2026-05-29 | LLY Mar avg: -2.32% median: -3.53% win: 50% σ: 10.95% n: 4 2022-04-12 → 2026-05-29 | LLY Apr avg: 4.14% median: 1.61% win: 80% σ: 8.04% n: 5 2022-04-12 → 2026-05-29 | LLY May avg: 4.22% median: 7.29% win: 80% σ: 13.38% n: 5 2022-04-12 → 2026-05-29 | LLY Jun avg: 7.17% median: 7.44% win: 100% σ: 3.19% n: 4 2022-04-12 → 2026-05-29 (current) | LLY Jul avg: -4.41% median: -4.07% win: 25% σ: 5.32% n: 4 2022-04-12 → 2026-05-29 | LLY Aug avg: 7.91% median: 9.18% win: 50% σ: 15.07% n: 4 2022-04-12 → 2026-05-29 | LLY Sep avg: 0.18% median: 0.54% win: 50% σ: 6.83% n: 4 2022-04-12 → 2026-05-29 | LLY Oct avg: 5.46% median: 7.55% win: 75% σ: 9.05% n: 4 2022-04-12 → 2026-05-29 | LLY Nov avg: 7.42% median: 4.59% win: 75% σ: 12.32% n: 4 2022-04-12 → 2026-05-29 | LLY Dec avg: -1.45% median: -1.39% win: 0% σ: 1.17% n: 4 2022-04-12 → 2026-05-29 |